Business Description
BioNxt Solutions Inc
NAICS : 325412
SIC : 3799
ISIN : CA0909741062
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -10.32 | |||||
Debt-to-Equity | -0.76 | |||||
Debt-to-EBITDA | -1.04 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -160.89 | |||||
Beneish M-Score | -25.64 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.6 | |||||
3-Year EBITDA Growth Rate | 38.6 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 33.2 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.97 | |||||
9-Day RSI | 57.23 | |||||
14-Day RSI | 57.58 | |||||
6-1 Month Momentum % | -25.83 | |||||
12-1 Month Momentum % | -55.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.04 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 1545.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -19.9 | |||||
Shareholder Yield % | -9.65 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -13007.14 | |||||
Net Margin % | -15423.81 | |||||
FCF Margin % | -7806.9 | |||||
ROA % | -563.6 | |||||
ROIC % | -101.77 | |||||
ROC (Joel Greenblatt) % | -968.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 76.18 | |||||
EV-to-EBIT | -7.11 | |||||
EV-to-EBITDA | -7.26 | |||||
EV-to-Revenue | 930.29 | |||||
EV-to-FCF | -11.85 | |||||
Earnings Yield (Greenblatt) % | -14.06 | |||||
FCF Yield % | -9.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BioNxt Solutions Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.029 | ||
EPS (TTM) (€) | -0.042 | ||
Beta | 2.05 | ||
Volatility % | 75.05 | ||
14-Day RSI | 57.58 | ||
14-Day ATR (€) | 0.022026 | ||
20-Day SMA (€) | 0.17545 | ||
12-1 Month Momentum % | -55.03 | ||
52-Week Range (€) | 0.103 - 0.528 | ||
Shares Outstanding (Mil) | 113.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BioNxt Solutions Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BioNxt Solutions Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BioNxt Solutions Inc Frequently Asked Questions
What is BioNxt Solutions Inc(STU:BXT)'s stock price today?
When is next earnings date of BioNxt Solutions Inc(STU:BXT)?
Does BioNxt Solutions Inc(STU:BXT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |